Business Daily from THE HINDU group of publications
Wednesday, Sep 13, 2006
ePaper
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Marketing - New Products & Services
Industry & Economy - Health
Get Latest BSE Quote
Ranbaxy launches asthma drug

Our Bureau

New Delhi, Sept. 12

Ranbaxy Laboratories Ltd today announced the launch of its Avessa inhalation capsules in the country for the treatment of asthma. Avessa (Formoterol plus Fluticasone) is available as Rheocaps Avessa 100 mcg, Avessa 250 mcg and 500 mcg and is to be used with the Rheohaler, a capsule based multidose dry powder inhaler, the drugmaker said.

More Stories on : New Products & Services | Health | Pharmaceuticals | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BSNL drops tariffs to Lanka, West Asia

P-G diploma in visual merchandising
Call for leveraging IT for the auto industry
Coke plans ad on product safety
`Delhi could be next global retail destination'
MASH plans study of shopper behaviour
Godrej unveils Godrej Interio
Dish TV to break even in two years
Cable row leaves cricket buffs in the lurch
Grasim launches five new fabrics
Ultra thin wide LCD monitors
Ranbaxy launches asthma drug

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line